MiR-218-5p/EGFR Signaling in Arsenic-Induced Carcinogenesis

Area of Science:

• Molecular Biology
• Cancer Research
• Toxicology

Background:

• Arsenic is a known carcinogen linked to various cancers, including lung cancer.
• Abnormal epidermal growth factor receptor (EGFR) expression is implicated in lung cancer progression and treatment resistance.
• The mechanism behind arsenic-induced EGFR upregulation is not fully understood.

Purpose of the Study:

• To investigate the role of miR-218-5p in arsenic-induced lung carcinogenesis.
• To elucidate the relationship between miR-218-5p and EGFR in arsenic-transformed cells.
• To explore the therapeutic potential of the miR-218-5p/EGFR pathway in arsenic-induced lung cancer.

Main Methods:

• Quantitative reverse transcription PCR (RT-PCR) and immunoblotting to assess miR-218-5p and EGFR expression.
• Luciferase assay to confirm direct targeting of EGFR by miR-218-5p.
• In vitro and in vivo assays (cell proliferation, migration, colony formation, tube formation, tumor growth) to evaluate miR-218-5p function.

Main Results:

• Arsenic-induced transformed (As-T) cells showed significantly upregulated EGFR and downregulated miR-218-5p.
• MiR-218-5p demonstrated tumor suppressor activity, inhibiting cell proliferation, migration, colony formation, tube formation, tumor growth, and angiogenesis.
• MiR-218-5p directly targets the 3'-untranslated region (UTR) of EGFR, inhibiting its expression and function.

Conclusions:

• The miR-218-5p/EGFR signaling pathway plays a critical role in arsenic-induced carcinogenesis and angiogenesis.
• Modulating the miR-218-5p/EGFR axis offers a promising therapeutic avenue for lung cancer resulting from chronic arsenic exposure.